Leptogenesis beyond the limit of hierarchical heavy neutrino masses

We calculate the baryon asymmetry of the Universe in thermal leptogenesis beyond the usual lightest right-handed (RH) neutrino dominated scenario (N_1DS) and in particular beyond the hierarchical limit (HL), M_1 << M_2 << M_3, for the RH neutrino mass spectrum. After providing some orientation among the large variety of models, we first revisit the central role of the N_1DS, with new insights on the dynamics of the asymmetry generation and then discuss the main routes departing from it, focusing on models beyond the HL. We study in detail two examples of `strong-strong' wash-out scenarios: one with `maximal phase' and the limit of very large M_3, studying the effects arising when delta_2=(M_2-M_1)/M_1 is small. We extend analytical methods already applied to the N_1DS showing, for example, that, in the degenerate limit (DL), the efficiency factors of the RH neutrinos become equal with the single decay parameter replaced by the sum. Both cases disprove the misconception that close RH neutrino masses necessarily lead to a final asymmetry enhancement and to a relaxation of the lower bounds on M_1 and on the initial temperature of the radiation-dominated expansion. We also explain why leptogenesis tends to favor normal hierarchy compared to inverted hierarchy for the left-handed neutrino masses.Comment: 30 pages, 8 figures; corrected typo in Eq. (67); shortened Introduction, Section 3 and Conclusions; one figure removed; added 2 references; to appear in JCA

Radiosurgery for the control of glomus jugulare tumours

Objective: To ascertain the efficacy of stereotactic radiosurgery (gamma knife) for the control of glomus jugulare tumours.Method: Between March 1994 and December 1997 we treated eight patients of glomus jugulare tumour with radiosurgery. These patients have been followed for more than four years (range 52 to 97 months). The age of the patients ranged between 32-64 years (mean 53 years). The male: female ratio was 3:5. Three patients had previously undergone surgery and one had unsuccessful embolization. The dose applied to tumour margin ranged between 16-25 Gy (median 25 Gy). Patients were followed up with yearly MRI scans and where possible with cerebral angiography.Results: All patients showed stabilisation of their symptoms following radiosurgery and six improved clinically. Five of these patients showed decrease in the size of lesion seen objectively on radiology, either slight to moderate decrease seen on the MRI scan or reduction in size and vascularity seen on cerebral angiography. The procedure is minimally invasive and none of the patients showed any adverse effect to radiosurgery.Conclusion: These results are encouraging but because of its naturally slow growth rate, up to 10 years of follow up will be necessary to establish a cure rate after radiosurgery for these lesions

Performance of optimised prosthetic ankle designs that are based on a hydraulic variable displacement actuator (VDA)

Current energy storage and return (ESR) prosthetic feet only marginally reduce the cost of amputee locomotion compared to basic solid ankle cushioned heel (SACH) feet, possibly due to their lack of push-off at the end of stance. To our knowledge, a prosthetic ankle that utilises a hydraulic variable displacement actuator (VDA) to improve push-off performance has not previously been proposed. Therefore, here we report a design optimisation and simulation feasibility study for a VDA based prosthetic ankle. The proposed device stores the eccentric ankle work done from heel strike to maximum dorsiflexion in a hydraulic accumulator and then returns the stored energy to power push-off. Optimisation was used to establish the best spring characteristic and gear ratio between ankle and VDA. The corresponding simulations show that, in level walking, normal push-off is achieved and, per gait cycle, the energy stored in the accumulator increases by 22% of the requirements for normal push-off. Although the results are promising, there are many unanswered questions and, for this approach to be a success, a new miniature, low-losses, lightweight VDA would be required that is half the size of the smallest commercially available device

Leptogenesis implications in models with Abelian family symmetry and one extra real Higgs singlet

We show that the neutrino models, as suggested by Low, which have an additional Abelian family symmetry and a real Higgs singlet to the default see-saw do not hinder the possibility of successful thermal leptogenesis. For these models (neglecting radiative effects), we have investigated the situation of strong washout in both the one-flavor approximation and when flavor effects are included. The result is that while such models predict that theta_{13}=0 and that one light neutrino to be massless, they do not modify or provide significant constraints on the typical leptogenesis scenario where the final asymmetry is dominated by the decays of the lightest right-handed neutrinos.Comment: 18 pages, RevTeX4, accepted by Phys. Rev. D. v2: minor corrections, note and 1 ref. added, same content as published versio

The role of magnetic resonance cholangiopancreatography (MRCP) in obstructive jaundice

Objective: To evaluate the diagnostic value of MRCP in studying the sites and cause of obstructive jaundice in comparison with other imaging modalities at the Department of Radiology, Aga Khan University Hospital, from January 1999 to May 2001.Methods: Forty nine consecutive patients included 19 men and 30 women, suspected of obstructive jaundice. Patients underwent ultrasound (n = 49), CT (n = 11), ERCP (n = 25) and biliary surgery (n = 17). Final diagnosis was established by surgical exploration, endoscopic sphincterectomy, cytology and clinical follow up.Results: Of the 49 patients 17 had choledocholithiasis. Twenty five patients had malignant strictures, out of which 11 had non-specific malignant strictures, 7 had pancreatic carcinoma, 3 had Klatskin tumors, 3 had periampullary carcinoma and 1 had gallbladder carcinoma. Six patients had benign strictures and 1 patient had choledochal cyst. Overall, MRCP was sensitive (88%) and specific (96.8%) in detecting choledocholithiasis. MRCP sensitivity and specificity in detecting benign main bile duct stricture was equal to 83.3% and 97.6% respectively, and 92% and 100% for malignant stricture.CONCLUSION: Our prospective study confirms that MRCP, a noninvasive and well tolerated imaging technique is of value in the diagnosis of obstructive jaundice

Biorthogonal quantum mechanics

The Hermiticity condition in quantum mechanics required for the characterization of (a) physical observables and (b) generators of unitary motions can be relaxed into a wider class of operators whose eigenvalues are real and whose eigenstates are complete. In this case, the orthogonality of eigenstates is replaced by the notion of biorthogonality that defines the relation between the Hilbert space of states and its dual space. The resulting quantum theory, which might appropriately be called 'biorthogonal quantum mechanics', is developed here in some detail in the case for which the Hilbert-space dimensionality is finite. Specifically, characterizations of probability assignment rules, observable properties, pure and mixed states, spin particles, measurements, combined systems and entanglements, perturbations, and dynamical aspects of the theory are developed. The paper concludes with a brief discussion on infinite-dimensional systems. © 2014 IOP Publishing Ltd

Veterinary Regenerative Medicine for Musculoskeletal Disorders: Can Mesenchymal Stem/Stromal Cells and Their Secretome Be the New Frontier?

Regenerative medicine aims to restore the normal function of diseased or damaged cells, tissues, and organs using a set of different approaches, including cell-based therapies. In the veterinary field, regenerative medicine is strongly related to the use of mesenchymal stromal cells (MSCs), which belong to the body repair system and are defined as multipotent progenitor cells, able to self-replicate and to differentiate into different cell types. This review aims to take stock of what is known about the MSCs and their use in the veterinary medicine focusing on clinical reports on dogs and horses in musculoskeletal diseases, a research field extensively reported in the literature data. Finally, a perspective regarding the use of the secretome and/or extracellular vesicles (EVs) in the veterinary field to replace parental MSCs is provided. The pharmaceuticalization of EVs is wished due to the realization of a Good Manufacturing Practice (GMP product suitable for clinical trials